Abstract: Blood brain barrier disruption enhances drug delivery in primary central nervous system lymphoma. In this study, we report adverse events that were encountered intraoperatively and in the postoperative period in these patients. A retrospective analysis of 17 patients documenting demographic data, preprocedure medical history, intraoperative, and postoperative anesthetic complications was conducted between January 2002 and December 2004. Seventeen patients underwent 210 treatments under general anesthesia with a mean of 12.4 ± 7.2 treatments per patient. Focal seizures occurred in 13% of patients. Generalized motor seizures occurred in 4 treatment sessions in 2 different patients. The incidence of seizures was significantly higher when the internal carotid artery was used for injection, as opposed to the vertebral artery (20.8% and 6.02%, respectively, P = 0.0034). Tachycardia associated with ST segment depression occurred 9 times (4.3%) in 3 patients. One patient had significant ST segment elevation (more than 1.5 mm). Transient cerebral vasospasm after methotrexate injection occurred in 9% of patients. Postoperative nausea and vomiting were observed in 11.9% of patients. After emergence, lethargy and obtundation occurred in 7.6% of the cases. The incidence of postoperative headache and reversible motor deficits was 6% and 3.8%, respectively. Our review highlights the problems that were encountered during blood brain barrier disruption under anesthesia and in the postoperative period. Further prospective studies are required for comprehensive evaluation of intraprocedure and postprocedure complications that will allow development of an optimal anesthetic plan and will improve patient outcome by preventing potential complications.
O smotic blood brain barrier disruption (BBBD) by rapid intra-arterial infusion of hyperosmolar solutions has been shown to improve delivery of chemotherapeutic drugs in primary central nervous system lymphomas in experimental studies 1 and clinically in human studies. 2, 3 This procedure is performed under general anesthesia because intra-arterial injection of hypertonic solutions is painful. Various anesthetic techniques might have important influences on obtaining optimal BBBD. 4, 5 Although complication rates associated with this procedure are low, it poses several challenges for the anesthesiologist. The aim of this retrospective study was to determine the incidence of the adverse events intraoperatively and in the postoperative period in these patients.
MATERIALS AND METHODS
After obtaining Institutional Review Board approval, we conducted a retrospective review of the charts of the 17 patients who underwent BBBD between January 2002 and December 2004. Demographic data, preprocedure medical history, intraoperative, and postoperative anesthetic complications were documented. In all patients, general endotracheal anesthesia was administered according to a predefined protocol. Thiopental (5 to 7 mg/kg) and fentanyl (1 to 2 mcg/kg) were used for induction of anesthesia. Succinylcholine was used to facilitate intubation of the trachea in a dose of 1 to 2 mg/kg. Anesthesia was maintained with isoflurane 1.5% in a mixture of oxygen/air (50%). Rocuronium or pancuronium was used in titrated doses to maintain muscle relaxation during the procedure. A Train-of-Four muscle twitch monitor was kept at 1 out of 4 twitches at all times with incremental doses of muscle relaxant. At our institution, the anesthesia protocol included predisruption administration of a single dose of ephedrine with a titrated single dose of atropine acutely to the patient's baseline heart rate and medical history to transiently reverse the cardiac output and enhance the delivery of chemotherapeutic agents to the brain. The protocol also included administration of thiopental and benzodiazepines before disruption to increase the seizure threshold for these patients. Twenty percent mannitol was infused into the internal carotid artery or vertebral artery over 30 seconds at a rate of 4 to 7 mL/s in most of the cases. BBBD was verified both clinically by unilateral dilation of the ipsilateral pupil 6 and under fluoroscopy. 7 This was followed by injection of methotrexate (1.5 to 5 g) into the cannulated artery, after which contrast material was injected into the cannulated artery. After infusion of the chemotherapy (methotrexate), nonionic contrast dye is given intravenously and the patient transported for a computed tomography scan to determine and document the degree of blood-brain barrier (BBB) opening.
RESULTS
Seventeen patients underwent 210 treatments under general anesthesia with a mean of 12.4 ± 7.2 (mean ± SD) treatments per patient. Our patients consisted of 13 women and 4 men with a mean age of 54 ± 13.8 years. The principal diagnosis of all these patients was primary central nervous system lymphoma ( Fig. 1) . Magnetic resonance imaging of the brain showed posterior periventricular diffusion and uniform enhancement characteristic of the primary intracranial lymphoma. Figure 2 shows complete resolution of the primary intracranial lymphoma after the BBBD procedure in the same patient. In Figure 3 , extravasation of contrast can be seen during the BBBD procedure. Seizures occurred in 9 patients during 29/210 treatments (13%). They were typically focal motor (in 25 treatments) and occurred at any time after BBBD. Generalized motor seizures occurred in 4 treatment sessions in 2 different patients. Table 1 shows the contingency analysis of seizures occurring during BBBD through internal carotid artery and vertebral artery. The incidence of seizures was significantly higher when the internal carotid artery was used for injection, as opposed to the vertebral artery (20.8% and 6.02% respectively, P = 0.0034) and was treated with intravenous sodium thiopental. All the seizures happened in the very early part of the operative period either on the way to the postanesthesia care unit or just on arrival to the postanesthesia care unit. Tachycardia associated with ST segment depression occurred 9 times (4.3%) in 3 patients, of whom 2 had a history of hypertension. This was treated with intravenous esmolol 1 to 2 mg/kg. The ST segment returned to baseline after treatment in all cases. One patient had significant ST segment elevation (more than 1.5 mm) with no associated tachycardia, which may suggest a central mechanism rather than a cardiac event in this particular patient. Postoperative electrocardiogram and cardiac enzymes in all affected patients were normal without evidence of cardiac ischemic insult. Vasospasm was a radiologic finding after methotrexate injection in 9% of the cases. However, it was transient and did not require treatment.
One treatment was aborted because of dissection of the left vertebral artery during injection. Another patient had to undergo decompressive hemispherectomy the next day because of severely increased intracranial pressure. Despite routine prophylaxis with 20 mg ondansetron, in all cases, the incidence of Postoperative nausea and vomiting (PONV) was 11.9%. After emergence, lethargy, and obtundation occurred as assessed by the neurosurgeon in 7.6% of the cases with recovery to baseline mental status in less than 24 hours in all patients. The incidence of postoperative headache and reversible motor deficits was 6% and 3.8%, respectively. Table 2 summarizes the complications during the procedure.
DISCUSSION
Anesthetic complications during BBBD treatments have not been previously reported. Adverse events related to BBBD can be either due to the toxicity of the chemotherapeutic drugs or due to the procedure itself. The major complication reported has been seizures that can occur before, 8 during, 2 or after 9 the procedure. The correlation between intra-arterial BBBD with mannitol and the development of seizures in humans and in a large animal model of osmotic BBB opening has been recently reported by Marchi et al. 10 They report that acute, transient openings of the BBB lead to behavioral and electrographic seizures that correlate with the degree of BBB disruption. In the present study, we showed that the incidence of seizures was significantly higher when the internal carotid artery was used for injection, compared with vertebral artery injection, where all the seizures occurred in the immediate postoperative period.
The procedure of BBBD was first described in 1940s by Broman and Olsson. 11 Since then various substances have been studied for their ability to transiently disrupt the BBB to the chemotherapeutic agents. 12 To date, intracarotid infusion of hypertonic solutions is the only method available for reversible BBBD. Out of all the hypertonic solutions available, mannitol is used most commonly in humans and is believed to cause osmotic shrinkage of endothelial cells, which subsequently causes temporary separation of the tight junctions. 13, 14 With intra-arterial delivery of mannitol, a decrease in regional blood flow improves drug deposition. The transient increase in cardiac output before the disruption of the BBB was aimed to increase the delivery of the chemotherapeutic agent into the brain without altering the uniform drug distribution to the brain after intra-arterial injection. The optimum drug distribution to the brain tissue is dependent on the proper mixing of the chemotherapeutic agent with the blood, which is dependent on the rate of injection. The faster the injection rate the better the mixing and uniform drug delivery to the brain tissue. 15 Second messenger systems involving calcium influx and Time for occurrence of the seizures: all the seizures happened in the immediate postoperative period, either while transferring the patient to the post anesthesia care unit (PACU) or just on arrival to the PACU.
ICA indicates internal carotid artery; VA, vertebral artery. Choice of anesthetic agents, ventilation protocols, and the role of agents to enhance tumor blood flow have been extensively investigated. 4 Remsen et al 4 showed that propofol-nitrous oxide anesthesia was better than isoflurane-oxygen in optimizing osmotic BBBD for delivery of chemotherapeutic drugs to brain tumor and normal brain. It has been shown in an animal study that the differences in BBBD using different anesthetic agents could be eliminated by normalizing blood pressure (BP) and cardiac output, suggesting that such anesthetic effects are mainly due to their cardiovascular effects. 5 General anesthesia offers several advantages, including superior patient comfort, seizure control through elevation of the seizure threshold, and control of intracranial pressure and cerebral edema, evoked by intra-arterial injection of relatively large volume mannitol 25% over a short period of time. Although there is a potential for neurologic and non-neurologic side effects, the procedure is deemed to be safe in the hands of teams with expertise in large regional centers. Neurologic side effects are seizures, increased ICP, and postoperative neurologic deficits, which include cognitive dysfunction, motor weakness, lethargy, and obtundation. Non-neurologic complications include PONV and ST segment changes. The incidence of PONV in our series was 11.9%, despite routine prophylaxis before extubation. This can be attributed mainly to the effect of the systemic chemotherapy that is administered in conjunction with the disruption procedure, and the effect of the general anesthetics. In our opinion, the anesthetic management of these cases should maintain hemodynamic stability with tight control of BP and cardiac output to ensure the maximum delivery of the chemotherapeutic agent to the target area of the brain. At our institution, we keep the patients intubated until they are completely recovered from anesthesia. The anesthetic management should use short acting anesthetic agents like desflurane and propofol to allow earlier recovery for neurologic assessment. Physiologic modification such as, transient increased BP and cardiac output during anesthesia just before the disruption of BBB offers the potential to increase targeted drug delivery to the tumors and might be useful in optimizing other potential techniques that are being used besides delivery of chemotherapeutic agents. Although small and retrospective, our review highlights the problems that were encountered during BBBD under anesthesia and in the postoperative period. Further prospective studies are required to develop regimens that minimize perioperative complications and improve patient outcome.
